{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:00:53Z","timestamp":1791687653416,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1136\/ard.61.6.530","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:35Z","timestamp":1027766735000},"page":"530-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products"],"prefix":"10.1016","volume":"61","author":[{"given":"H J","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Mouritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Christgau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A C","family":"Cloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.6.530_bib1","first-page":"6","article-title":"The increasing impact of arthritis on public health","volume":"60","author":"Elders","year":"2000","journal-title":"J Rheumatol Suppl"},{"key":"10.1136\/ard.61.6.530_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0003-4967(24)43379-7","article-title":"Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages","volume":"60","author":"Boinin","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.6.530_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S8756-3282(01)00504-X","article-title":"Collagen type II C-telopeptide fragments as an index of cartilage degradation","volume":"29","author":"Christgau","year":"2001","journal-title":"Bone"},{"key":"10.1136\/ard.61.6.530_bib4","first-page":"1492","article-title":"Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group","volume":"85","author":"Ravn","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.61.6.530_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S8756-3282(96)00229-3","article-title":"The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study","volume":"19","author":"Ravn","year":"1996","journal-title":"Bone"},{"key":"10.1136\/ard.61.6.530_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.6.530_bib7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III OsteoporosisTreatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.6.530_bib8","first-page":"1972","article-title":"Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis","volume":"26","author":"Podworny","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.6.530_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000028204","article-title":"Inhibitory effects of TRK-530 on rat adjuvant arthritis","volume":"56","author":"Tanahashi","year":"1998","journal-title":"Pharmacology"},{"key":"10.1136\/ard.61.6.530_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S8756-3282(01)00431-8","article-title":"The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone","volume":"28","author":"Garnero","year":"2001","journal-title":"Bone"},{"key":"10.1136\/ard.61.6.530_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S8756-3282(00)00248-9","article-title":"Serum crosslaps for monitoring the response in individuals undergoing antiresorptive therapy","volume":"26","author":"Christgau","year":"2000","journal-title":"Bone"},{"key":"10.1136\/ard.61.6.530_bib12","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/clinchem\/44.11.2281","article-title":"Serum Crosslaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen","volume":"44","author":"Rosenquist","year":"1998","journal-title":"Clin Chem"},{"key":"10.1136\/ard.61.6.530_bib13","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/clinchem\/44.11.2290","article-title":"Clinical evaluation of the Serum Crosslaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides","volume":"44","author":"Christgau","year":"1998","journal-title":"Clin Chem"},{"key":"10.1136\/ard.61.6.530_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0945-053X(01)00188-3","article-title":"Non enzymatic covalent modification of proteins: mechanisms, physiological consequences and clinical applications","volume":"21","author":"Cloos","year":"2002","journal-title":"Matrix Biol"},{"key":"10.1136\/ard.61.6.530_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.60.6.619","article-title":"Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage","volume":"60","author":"Garnero","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.6.530_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002281-199805000-00019","article-title":"The effects of estrogen on osteoarthritis","volume":"3","author":"Felson","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.61.6.530_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S8756-3282(96)00184-6","article-title":"Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106","volume":"4","author":"Yu","year":"1996","journal-title":"Bone"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724093439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724093439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.6.530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:40:08Z","timestamp":1737243608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724093439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0003496724093439"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.6.530","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.6.530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}